NASDAQ:ANCN
Delisted
Anchiano Therapeutics Ltd Stock News
$4.47
+0 (+0%)
At Close: Aug 17, 2022
ANCN Stock Price Increases Over 30% Pre-Market: Why It Happened
06:01am, Tuesday, 16'th Mar 2021
The stock price of Anchiano Therapeutics Ltd. (Nasdaq: ANCN) increased by over 30% pre-market.
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
05:54pm, Monday, 15'th Mar 2021
Anchiano s hareholders approve all resolutions at shareholder meeting
Why Immunovant, Anchiano, OpGen Are Rallying Today
01:09pm, Monday, 08'th Mar 2021
Immunovant, Inc. (NASDAQ: IMVT), Anchiano Therapeutics Ltd. (NASDAQ: ANCN) and OpGen, Inc. (NASDAQ: OPGN) are among the biggest healthcare gainers on Monday.
ANCN Stock: Speculation Around Investor Letter Sends Anchiano Therapeutics Soaring
10:22am, Monday, 08'th Mar 2021
Anchiano Therapeutics (ANCN) stock is rocketing higher on Monday after a shareholder letter caught the interest of investors. The post ANCN Stock: Speculation Around Investor Letter Sends Anchiano The
ANCN Stock Price Increases Over 100% Pre-Market: Why It Happened
05:15am, Monday, 08'th Mar 2021
The stock price of Anchiano Therapeutics Ltd (NASDAQ:ANCN) increased by over 100% pre-market. This is why it happened.
ANCN Stock Price Increased 184.29%: Why It Happened
09:29pm, Wednesday, 10'th Feb 2021
The stock price of Anchiano Therapeutics Ltd (NASDAQ: ANCN) increased by 184.29%. This is why it happened.
ANCN Stock: 10 Things to Know as Anchiano Therapeutics Rockets Higher
03:33pm, Wednesday, 10'th Feb 2021
ANCN stock is an early stage company engaged in clinical trials for rare liver, lung and skin diseases with no FDA-approved options now. The post ANCN Stock: 10 Things to Know as Anchiano Therapeutics
Lifshitz Law Firm, P.C. Announces Investigation of ANCN, BEAT, HMSY, SNCA, SPWH, TCP, TRP, TLRY, and APHA
11:49pm, Thursday, 24'th Dec 2020
NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Anchiano Therapeutics Ltd. (NASDAQ: ANCN) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger
SHAREHOLDER ALERT: WeissLaw LLP Investigates Anchiano Therapeutics Ltd.
05:16pm, Tuesday, 15'th Dec 2020
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Anchiano Therapeutics Ltd. ("Anchiano
ANCN Stock: Why Anchiano Therapeutics Stock Is Blasting Higher Today
12:01pm, Tuesday, 15'th Dec 2020
Anchiano Therapeutics (ANCN) stock is soaring higher on Tuesday following news of a merger with Chemomab that will bring major changes. The post ANCN Stock: Why Anchiano Therapeutics Stock Is Blasting
Anchiano Appoints Stan Polovets as Chairman of the Board
12:00pm, Tuesday, 26'th May 2020
Anchiano Therapeutics Ltd. (ANCN) (the “Company”) today announced that Mr. Stan Polovets has been elected chairman of its board of directors. Mr. Polovets joined the board of Anchiano in April 20
Anchiano Therapeutics Reports First Quarter 2020 Financial Results
08:01pm, Monday, 11'th May 2020
CAMBRIDGE, Mass., May 11, 2020 -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a preclinical biopharmaceutical company dedicated to the discovery and development of.
Anchiano Appoints Steve DiPalma as Chief Financial Officer
10:13pm, Tuesday, 05'th May 2020
Anchiano Therapeutics Ltd. (ANCN) (the “Company”) today announced it has appointed Mr. Steve DiPalma as its Chief Financial Officer. Mr. DiPalma has served as a Senior Financial Advisor to Anchia
Anchiano to Hold Virtual Annual Meeting of Shareholders
08:01pm, Friday, 17'th Apr 2020
Anchiano Therapeutics Ltd. (ANCN) (the “Company”) today announced it has elected to hold its 2020 Annual General Meeting of Shareholders (the “Annual Meeting”) as a virtual meeting due to the
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
